Home > Research Institute > Available Trials > Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)
Disease Types: Myelomas
Available at: Roanoke
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)
For More Information:
https://clinicaltrials.gov/study/NCT05972135?term=Teclistamab%20in%20Multiple%20myeloma&rank=2